No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (Q74260794)
Jump to navigation
Jump to search
scientific article published on 01 August 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) |
scientific article published on 01 August 2000 |
Statements
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (English)
J Y Cahn
M Labopin
J Sierra
D Blaise
J Reiffers
A Ferrant
L Bergmann
G Visani
J Cornelissen
T De Witte